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Abstract
Background—The Pediatric Heart Network Collaborative Learning Study (PHN CLS) increased 
early extubation rates after infant tetralogy of Fallot (TOF) and coarctation of the aorta (CoA) 
repair across participating sites by implementing a clinical practice guideline (CPG). The impact 
of the CPG on hospital costs has not been studied.
Methods—PHN CLS clinical data were linked to cost data from Children’s Hospital Association 
by matching on indirect identifiers. Hospital costs were evaluated across active and control sites in 
the pre- and post-CPG periods using generalized linear mixed-effects models. A difference-in-
difference approach was used to assess whether changes in cost observed in active sites were 
beyond secular trends in control sites.
Results—Data were successfully linked on 410 of 428 eligible patients (96%) from four active 
and four control sites. Mean adjusted cost per case for TOF repair was significantly reduced in the 
post-CPG period at active sites ($42,833 vs $56,304, p < 0.01) and unchanged at control sites 
($47,007 vs $46,476, p = 0.91), with an overall cost reduction of 27% in active versus control sites 
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(p = 0.03). Specific categories of cost reduced in the TOF cohort included clinical (−66%, p < 
0.01), pharmacy (−46%, p = 0.04), lab (−44%, p < 0.01), and imaging (−32%, p < 0.01). There 
was no change in costs for CoA repair at active or control sites.
Conclusions—The early extubation CPG was associated with a reduction in hospital costs for 
infants undergoing repair of TOF but not CoA. This CPG represents an opportunity to both 
optimize clinical outcome and reduce costs for certain infant cardiac surgeries.
In the current healthcare environment there is increasing emphasis on both improving 
quality of care and reducing costs, or providing high “value” care. Congenital heart disease 
accounts for the highest hospital costs among all children with birth defects and is among 
the most frequent high-cost conditions treated at children’s hospitals across all pediatric 
diseases [1, 2].
Few studies have evaluated specific interventions that may hold the potential to both 
improve clinical outcomes and lower costs in this population. The Pediatric Heart Network 
Collaborative Learning Study (PHN CLS) [3] demonstrated that a collaborative learning 
strategy involving development and implementation of a clinical practice guideline (CPG) 
was successful in significantly increasing the rate of early extubation (extubation within 6 
hours of admission to the intensive care unit) in infants undergoing repair of tetralogy of 
Fallot (TOF) and coarctation of the aorta (CoA) at active sites compared with controls. At 
active sites the rate of early extubation increased from 11.7% to 66.9% (p < 0.001). Other 
key findings included a significant decline in postoperative critical care length of stay in the 
TOF group (44.2 vs 51.8 hours, p = 0.04), although there was no change in total hospital 
length of stay in either TOF or CoA patients. In addition, time to discontinuation of 
continuous intravenous analgesics and time to introduction of oral feeds were reduced after 
introducing the CPG with more prominent changes in the TOF group. It is not known 
whether these changes translated into reductions in hospital costs, because other practices 
and factors may have influenced cost of care for these patients across hospitals beyond the 
timing of extubation and associated factors [4, 5].
This study merges PHN CLS clinical data with cost data from the Children’s Hospital 
Association (CHA) Inpatient Essentials database to study the impact of the CPG on hospital 
costs. In addition to an assessment of total hospital costs in the pre- and post-CPG periods, 
we also evaluated specific cost categories to assess which of these may be impacted the 
most.
Patients and Methods
Data Sources
The PHN CLS was performed over a 2-year period from 2013 to 2015. The methods and 
main study results have been previously published [3, 6]. Briefly, the investigative team 
observed clinically important variation in postoperative mechanical ventilation practices and 
clinical outcomes after infant surgical procedures at five congenital heart programs [6]. One 
hospital was identified as a positive outlier with much lower median ventilation times and 
shorter length of stay. Participants engaged in a series of round-robin site visits and then 
created a CPG to mimic the extubation strategy and associated key practices at the “model” 
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hospital after infant repair of TOF and CoA. In the main study clinical outcomes at the four 
active hospitals who implemented the CPG were measured during the 12 months before 
(pre-CPG) and the 12 months after (post-CPG) implementation and were compared with 5 
other PHN sites during the same time period (controls) who continued with usual practice 
[3].
The Inpatient Essentials database (formally known as the Case Mix database) is a large 
administrative database maintained by CHA (Lenexa, KS). The database contains total 
hospital resource utilization and other inpatient data from 90 US children’s hospitals [7].
Linkage
PHN CLS clinical data and hospital cost data from the Inpatient Essentials database were 
linked at the patient level using the method of probabilistic matching of indirect identifiers 
as previously described [7, 8]. The following identifiers were used for record linkage: center, 
gender, date of admission (±1 day), date of discharge (±1 day), and date of birth (±1 day). 
The analysis performed for this project was a prespecified secondary aim of the primary 
PHN CLS, which was reviewed and approved by the PHN’s Data and Safety Monitoring 
Board, as well the individual centers’ Institutional Review Boards with waiver of informed 
consent.
Study Population
All patients enrolled in the PHN CLS were eligible for inclusion [3]. Similar to the main 
analysis the “model center” was excluded because it served as the prototype for CPG 
development. Additionally, one non-US center was excluded from the control sites because 
it did not contribute data to the CHA Inpatient Essentials database.
Data Collection
Data collected as a part of the PHN CLS have been previously reported [3]. All clinical data 
for this study were obtained from variables in the PHN CLS. Data contained in CHA 
Inpatient Essentials database were used to estimate hospital costs as described below. These 
data consist of daily total hospital charges, hospital and department specific cost-to-charge 
ratios, and daily line item charges for every service grouped into standard categories, 
including clinical, pharmacy, imaging, laboratory, supplies, and “other.” Of note, the “other” 
category is primarily composed of room and board costs, and the clinical service category 
includes costs related to testing, procedures, and other aspects of clinical care delivery such 
as mechanical ventilation and other respiratory care. Professional fees are not captured by 
the CHA or other frequently used administrative datasets and therefore could not be 
included in the analysis. The CHA does not separate out facility fees from other charges.
Analysis
Total hospital costs were estimated from charges using hospital and year specific cost-to-
charge ratios for the time periods before and after CPG implementation with a 3-month 
wash-out phase for each period. Hospital costs were adjusted for geographic region using the 
Centers for Medicare & Medicaid Services price wage index, and values were indexed to 
2015 US dollars to account for inflation.
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Total hospital costs were modeled as continuous variables in mixed-effects models. Separate 
models were constructed for the TOF and CoA patients. The skewed distribution of cost was 
accounted for by using a gamma distribution, and a random intercept was used for each 
hospital to account for patient clustering within center. Models were adjusted for any clinical 
variables that approached significance in bivariate analyses (p < 0.2), which included 
diagnosis type for the CoA cohort (Table 1).
These models were used in a difference-in-difference analysis. This approach, which uses 
econometric techniques, isolates changes in outcomes associated with an event of interest 
above and beyond any changes in a control group not exposed to the event or change [9–11]. 
This methodology allowed us to evaluate the impact of the CPG on hospital costs at active 
sites, taking into account cost trends during the study period at the control sites. This 
approach has been used across several fields to examine a number of outcomes before and 
after the implementation of various policies or initiatives [9, 12, 13].
Finally, in addition to total hospital costs, categories of cost described in the preceding 
sections were also assessed, followed by specific line items for which we anticipated there 
might be reductions given the clinical context and findings of the main CLS study. All 
analyses were performed using SAS version 9.4 (SAS Institute Inc, Cary, NC). A p < 0.05 
was considered to be statistically significant.
Results
Study Population
All four active PHN CLS sites and four control sites were included. As described in the 
preceding section, one model site and one non-US control site were excluded. From these 
sites data were successfully linked between the CLS PHN and CHA datasets on 410 of 428 
eligible patients (96%). The remaining 23 unmatched patients were distributed among 6 
sites, with a range of 0 to 5 unmatched patients per site.
Study population characteristics are displayed in Table 1. Median age at operation was 20 
days for CoA patients and 153 days for TOF. On average CoA patients underwent an 
operation on hospital day 4 with 74.3% of hospital costs occurring on or after the day of the 
surgical procedure. TOF patients underwent operation on average on hospital day 2 with 
85.9% of hospital costs occurring on or after the day of the surgical procedure.
TOF Costs Pre- and Post-CPG
The mean adjusted costs per case in the TOF cohort across the pre- and post-CPG periods 
are shown in Table 2. There was no significant difference in the pre-CPG hospital costs in 
the active versus control sites (p = 0.35). Assessing change over time at the active sites, there 
was a significant reduction in mean adjusted cost per case after CPG implementation 
($56,304 in pre-CPG period vs $42,833 in post-CPG period, p < 0.001). At the control sites 
there was no significant change from the pre- to post-CPG periods (Table 2). Overall our 
difference-in-difference analysis showed a 27% reduction in hospital costs in the active 
versus control sites (95% confidence interval, −42% to −13%; p = 0.03) in the TOF cohort.
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Specific categories of cost are displayed in Figure 1. We found the greatest reduction in 
hospital costs from the pre- to post-CPG period for the “clinical” category (−66%, p < 0.01). 
Notably for the purpose of this study the clinical category also includes costs related to 
mechanical ventilation and other respiratory care. Significant reductions were also seen for 
pharmacy (−46%, p = 0.04), laboratory (−44%, p < 0.01), and imaging (−32%, p < 0.01) 
costs. There was no significant change in supplies or other costs; of note the “other” 
category is primarily composed of room and board costs.
In addition to these overall categories we further examined specific line items of interest. 
Within the clinical category we found significant reductions in costs related to mechanical 
ventilation (−161 %, p = 0.03) and nebulized mist treatments (−110%, p = 0.04). In the 
pharmacy domain there were significant reductions for ketamine (−139%, p = 0.005) and 
fentanyl (−125%, p < 0.001). In the lab category blood gas costs were reduced (−39%, p = 
0.01), and there was a trend toward reduction of chest x-ray costs within the imaging domain 
(−22%, p = 0.07).
CoA Costs Pre- and Post-CPG
The mean adjusted costs per case in the CoA cohort across the pre- and post-CPG periods 
are shown in Table 2. There was no significant change in costs over time from the pre- to 
post-CPG periods in either the active or control sites for CoA repair.
Comment
In this study we merged PHN CLS clinical data with cost data from a large CHA dataset to 
study the impact of an early extubation CPG on hospital costs after infant cardiac surgical 
procedures. We found a significant reduction in hospital costs associated with the CPG for 
infants undergoing TOF repair, whereas there was no change in hospital costs for those 
undergoing CoA repair.
Although both cohorts in the study had increased rates of early extubation after CPG 
implementation in the primary study, the cost reduction we found in the present analysis was 
limited to the TOF group. These observations mirror those from the primary study [3], 
where improvements in some of the secondary endpoints examined were more prominent in 
the TOF group than the CoA group. These included reduced intensive care unit length of 
stay in the TOF group but not the CoA group, a more prominent decrease in time to 
discontinuation of all continuous sedation/analgesia in the TOF group compared with the 
CoA group, and significant declines in cumulative doses of specific sedation/analgesia 
medications in TOF patients compared with no change in CoA patients [3].
These findings were further highlighted by our examination of specific cost categories and 
line items that were reduced in the TOF cohort. With earlier extubation clinical costs, 
specifically those related to mechanical ventilation and respiratory care, were reduced. 
Consistent with the primary study findings regarding analgesia and sedation [3], pharmacy 
costs and related specific line items were also reduced. Despite the reduced intensive care 
unit length of stay [3], room and board costs (which comprised most of the “other” category) 
were not significantly reduced. This may be because the main CLS study demonstrated no 
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change in total hospital length of stay. Laboratory and imaging costs were lower, which 
could be related to the deescalation of care that is typically associated with transition from 
the intensive care unit and/or associated with the shorter duration of mechanical ventilation, 
as declines in costs related to blood gasses and chest x-rays were seen.
Within the CoA group we hypothesized that the hospital costs associated with noncardiac 
care of newborns with critical CoA may mask changes from a CPG focused on postoperative 
care, whereas in contrast most TOF patients are older infants likely admitted from home 
within 24 hours of the surgical procedure to undergo elective repair. We found that CoA 
patients did indeed have a longer preoperative hospital stay in our analysis, with a lower 
proportion of overall hospital costs related to the postoperative period compared with the 
TOF group.
The potential implications for cost savings related to implementation of this CPG are 
considerable. For example, recent data from the Society of Thoracic Surgeons Congenital 
Heart Surgery Database suggest approximately 1,250 TOF repairs occur annually in the 
United States [14]. Based on the cost estimates for TOF repair in our study and the 
magnitude of reduction associated with the CPG, this could translate into total cost savings 
of approximately $10 to 15 million each year for repair of TOF alone.
Through the use of data linkage techniques our study was able to provide unique insights 
that supplement the primary PHN CLS findings. Specifically by merging clinical PHN CLS 
data with administrative data from CHA through linking on indirect identifiers, we were able 
to understand the impact of the quality improvement initiative not only on clinical outcomes 
but costs of care as well. Similar techniques have been used to merge cost data with trial 
datasets and registry data [8, 15–18] and highlight how this methodology can foster 
investigations not otherwise possible with isolated datasets alone. The methods used in the 
present analysis can be applied to other quality initiatives to support more comprehensive 
understanding of healthcare value and the impact of various initiatives geared toward 
optimizing both clinical outcomes and costs of care.
Limitations
There are several limitations to consider. Our results relate to the two forms of infant heart 
operations examined as a part of the PHN CLS (TOF and CoA repair, both resulting in 
biventricular circulations and normal oxygen saturations) and may not be generalizable to all 
forms of congenital heart disease or outside of the context of the eight centers included in 
this analysis. Regarding the changes in hospital costs observed in our study, it is possible 
that these could be related to other general improvements in care over time rather than the 
early extubation CPG. However, the inclusion of control sites and use of a difference-in-
difference design to account for secular trends makes this unlikely. The observation of cost 
reductions in the categories that we would expect to be most impacted by the CPG based on 
the clinical findings also supports the validity of our findings. It is possible that our analysis 
was underpowered to detect small changes in hospital costs over time. In addition, although 
standard methods were used across hospitals to derive estimated hospital costs, it is possible 
that some cost differences were related more to hospital accounting practices and/or regional 
differences rather than to actual resources used. However, the design of this study, in which a 
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center’s data from the post-CPG era were compared with their data from the pre-CPG 
period, mitigates some of these concerns related to center effects. Finally, given the findings 
of the accompanying study in this issue of The Annals of Thoracic Surgery by Gaies and 
colleagues [19] regarding limited sustainability of the early extubation CPG practices and 
outcomes at most centers, it is possible that some of the gains described here may not persist 
over time. Further efforts are necessary to investigate strategies to support sustainability, 
whether related to clinical outcomes or hospital costs.
Conclusion
This study demonstrates that implementation of an early extubation CPG through a 
collaborative learning approach was associated with reduced hospital costs for certain infant 
cardiac surgeries, in addition to the improvement in certain clinical outcomes observed 
during the study period. With the ability to both reduce hospital costs and improve outcomes 
the early extubation CPG has potential to improve value in infant heart surgery. These results 
and the unique methodology used in this study can inform future initiatives aimed at 
improving healthcare value across other patient populations. Further investigation into 
strategies to promote sustainability is also necessary.
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Fig 1. 
Categories of cost for tetralogy of Fallot repair. Specific categories of cost in the tetralogy of 
Fallot cohort are displayed, with percent change from pre-CPG to post-CPG on the y-axis. 
Standard cost categories included clinical, pharmacy, imaging, laboratory, supplies, and 
“other.” The “other” category is primarily composed of room and board costs. Notable for 
the present study, the clinical category contains costs related to mechanical ventilation and 
other respiratory care. There was a significant reduction in clinical, pharmacy, laboratory, 
and imaging costs, whereas supply and other costs remained unchanged. (CPG = clinical 
practice guideline.)
McHugh et al. Page 9
Ann Thorac Surg. Author manuscript; available in PMC 2019 June 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
McHugh et al. Page 10
Ta
bl
e 
1.
St
ud
y 
Po
pu
la
tio
n 
Ch
ar
ac
te
ris
tic
s
C
oA
TO
F
C
ha
ra
ct
er
ist
ic
s
To
ta
l (n
 = 
16
3)
A
ct
iv
e 
(n
 = 
85
)
C
on
tr
o
ls 
(n
 = 
78
)
p
To
ta
l (n
 = 
24
7)
A
ct
iv
e 
(n
 = 
14
1)
C
on
tr
o
ls 
(n
 = 
10
6)
p
M
al
e
10
3 
(63
%)
53
 (6
2%
)
50
 (6
4%
)
0.
82
14
1 
(57
%)
78
 (5
5%
)
63
 (5
9%
)
0.
52
B
irt
h 
w
ei
gh
t, 
kg
3.
3 
12
.8
–3
.6
]
3.
3 
[2
.8–
3.6
]
3.
2 
[2
.9–
3.6
]
0.
84
3.
1 
[2
.7–
3.4
]
3.
1 
[2
.8–
3.5
]
3.
1 
[2
.8–
3.5
]
0.
56
G
es
ta
tio
na
l a
ge
 <
 3
7 
w
ee
ks
16
 (1
0.7
%)
8 
(10
.3%
)
8 
(11
.1%
)
0.
87
33
 (1
5.9
%)
20
 (1
6.1
%)
13
 (1
5.5
%)
0.
90
A
ge
 a
t s
ur
ge
ry
,
 
da
ys
20
 [7
–5
9]
19
 [7
–6
3]
20
.5
 [8
–5
2]
0.
99
15
3 
[1
12
–2
08
]
15
3 
[1
25
–1
98
]
15
2 
[9
2–
21
9]
0.
49
Ch
ro
m
os
om
al
 a
no
m
al
y 
D
ia
gn
os
is
1 
(0.
6%
)
1 
(1.
2%
)
0
0.
34
8 
(3.
2%
)
6 
(4.
3%
)
2 
(1.
9%
)
0.
30
D
ia
gn
os
is
 
Is
ol
at
ed
 c
oa
rc
ta
tio
n
64
 (3
9.3
%)
35
 (4
1.2
%)
29
 (3
7.2
%)
0.
18
N
A
 
Is
ol
at
ed
 c
oa
rc
ta
tio
n 
+ 
V
SD
 (n
ot 
req
uir
ing
 in
ter
ve
n
tio
n)
21
 (1
2.9
%)
7 
(8.
2%
)
14
 (1
7.9
%)
 
Co
ar
ct
at
io
n 
+ 
ot
he
r l
es
io
n
78
 (4
7.9
%)
43
 (5
0.6
%)
35
 (4
4.9
%)
 
TO
F 
+ 
PS
N
A
23
6 
(95
.5%
)
13
5 
(95
.7%
)
10
1 
(95
.3%
)
0.
98
 
TO
F 
+ 
AV
SD
9 
(3.
6%
)
5 
(3.
5%
)
4 
(3.
8%
)
 
TO
F 
+ 
ab
se
nt
 p
ul
m
on
ar
y 
va
lv
e
2 
(0.
8%
)
1 
(0.
7%
)
1 
(0.
9%
)
Co
nt
in
uo
us
 v
ar
ia
bl
es
 a
re
 re
po
rte
d 
as
 m
ed
ia
ns
 w
ith
 in
te
rq
ua
rti
le
 ra
ng
es
 in
 b
ra
ck
et
s.
AV
SD
 =
 a
tri
ov
en
tr
ic
ul
ar
 se
pt
al
 d
ef
ec
t; 
NA
 =
 n
ot
ap
pl
ic
ab
le
; P
S 
= 
pu
lm
on
ar
y 
ste
no
sis
; T
O
F 
= 
te
tra
lo
gy
 o
f F
al
lo
t; 
V
SD
 =
 v
en
tr
ic
ul
ar
 se
pt
al
 d
ef
ec
t.
Ann Thorac Surg. Author manuscript; available in PMC 2019 June 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
McHugh et al. Page 11
Ta
bl
e 
2.
Ch
an
ge
 in
 H
os
pi
ta
l C
os
ts 
Pr
e-
 V
er
su
s 
Po
st
-C
PG
G
ro
u
p
Pr
e-
C
PG
Po
st
-C
PG
C
ha
ng
e
Co
A
 R
ep
ai
r C
on
tro
l
$3
5,9
12
 ($
23
,75
4-$
54
,29
1)
$3
9,0
53
 ($
26
,45
9-$
57
,64
3)
8.
4%
 (−
25
%,
 41
.7%
) p
 = 
0.6
A
ct
iv
e
$4
4,5
35
 ($
32
,10
5-$
61
,77
7)
$3
9,1
96
 ($
27
,55
2-$
55
,76
4)
−
12
.8
%
 (−
41
.1%
, 1
5.6
%)
 p 
= 0
.4
D
iff
er
en
ce
-in
-d
iff
er
en
ce
 −
21
.2
%
 (−
65
.2%
, 2
2.9
%)
 p 
= 0
.3
TO
F 
Re
pa
ir 
Co
nt
ro
l
$4
7,0
07
 ($
32
,08
0-$
68
,88
2)
$4
6,4
76
 ($
31
,84
7-$
67
,82
3)
−
1.
1%
 (−
20
.1%
, 1
7.9
%)
 p 
= 0
.9
A
ct
iv
e
$5
6,3
04
 ($
40
,79
4-$
77
,71
1)
$4
2,8
33
 ($
31
,06
1-$
59
,06
7)
−
27
.3
%
 (−
41
.5%
, −
13
.2%
) p
 < 
0.0
01
D
iff
er
en
ce
-in
-d
iff
er
en
ce
 −
26
.2
%
 (−
49
.9,
 −2
.5)
 p 
= 0
.03
Ch
an
ge
 d
en
ot
es
 th
e 
pe
rc
en
t c
ha
ng
e 
fro
m
 p
re
- t
o 
po
st-
cl
in
ic
al
 p
ra
ct
ic
e 
gu
id
el
in
e 
(C
PG
) e
ras
.
Co
A
 =
 c
oa
rc
ta
tio
n 
of
 th
e 
ao
rta
; T
O
F 
= 
te
tra
lo
gy
 o
f F
al
lo
t.
Ann Thorac Surg. Author manuscript; available in PMC 2019 June 02.
